GLENMARK PHARMACEUTICALS LTD. | Scrip Code : 532296 | Quarter ending :December 2015 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 20 | 13,11,29,673 | 13,11,29,673 | 46.47 | | 0.00 | | 0.00 | 13,11,29,673 | - | - | - | (B) Public | 74,765 | 15,10,28,483 | 15,10,28,483 | 53.53 | | 0.00 | 1,08,00,000 | 7.15 | 14,89,40,879 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 74,785 | 28,21,58,156 | 28,21,58,156 | 100.00 | | 0.00 | 1,08,00,000 | 3.83 | 28,00,70,552 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|